User:Neuroimmune Pharmacologist/sandbox

Journal of Neuroimmune Pharmacology
The Journal of Neuroimmune Pharmacology (JNIP) is the official journal of the Society on NeuroImmune Pharmacology. Established in 2005 as a peer-reviewed, scientific journal, the journal interfaces the disciplines of immunology, pharmacology and experimental neuroscience.

Aims and Scope
JNIP seeks to: 1) promote the dissemination of new discoveries in pharmacology and immunology research relevant to nervous system biology and disease; 2) elucidate the molecular and biochemical effects that drugs of abuse have on the neuroimmune axis and influence nervous system function and disease; 3) acquire a better understanding of how the immune system is affected by neuropsychiatric, neuroinfectious, neuroimmune and neurodegenerative disorders and vice versa; 4) bridge cross-disciplinary and integrative research activities in the fields of pharmacology (pharmacokinetics and pharmacodynamics), immunology, and neuroscience; and 5) develop novel disease combating therapeutic strategies.

The journal includes original studies and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Special topic issues have provided an opportunity to bring together articles on the latest works in
 * Adaptive Immunity and Neurodegenerative Diseases
 * Animal Models for NeuroAIDS
 * Brain Metabolomics
 * Chronic Viral Infections of the Nervous System
 * Cell Signaling Pathways and HIV-1 Therapeutics
 * Global Health: Prevention and Treatment of Substance Abuse and HIV
 * Immune system regulation of cognitive function: opportunities for novel therapeutics


 * Marijuana and cannabinoids
 * Molecular Basis for Neuroimmune Receptor Signaling
 * Neuroimmune Pharmacological Control of experimental allergic encephalomyelitis
 * Neuroinflammation Imaging
 * Neuromics
 * Studies of Opiate and other drugs of abuse on immunity and microbial pathogenesis

History
Volume 1 was published in March 2006. The Journal was founded through the combined efforts of the Society on NeuroImmune Pharmacology, Ms. Andrea Macaluso Springer New York, and Dr. Howard E. Gendelman. Since its inception, Dr. Gendelman, editor-in-chief, has led the journal. JNIP has grown to include two senior editors, Kalipada Pahan, PhD and Irena Kadiu, and eight section editors:


 * Cell Signaling and Immunity (Thomas J. Rogers, PhD)
 * Drug Delivery and Nanomedicine (Ram Mahato, PhD)
 * Imaging and Biomarkers (Linda Chang, PhD)
 * Infectious Diseases and Immunomodulation (Steve Jacobson, PhD)
 * Natural Medicine (Raymond Chuen-Chung Chang, PhD)
 * Neuroactive and Abused Substances (Guy Cabral, PhD)
 * Neurodegenerative Disorders (Tsuneya Ikezu, MD, PhD)
 * Visual Neuromedicine (Harris Gelbard, MD, PhD)

Managing Editor, Robin Taylor

Abstracting and indexing
JNIP is abstracted and indexed in
 * Science Citation Index Expanded (SciSearch)
 * Journal Citation Reports/Science Edition
 * PubMed/Medline SCOPUS
 * EMBASE
 * Google Scholar
 * CSA
 * Academic OneFile
 * AGRICOLA
 * Biological Abstracts
 * BIOSIS
 * ChemWeb
 * Gale
 * Neuroscience Citation Index
 * OCLC
 * Summon by Serial Solutions